Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
株式のランク #29676
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
株価
$0.20877985
時価総額
$20.11M
変化(1日)
-3.03%
変化(1年)
-66.13%
JP
取引 Modalis Therapeutics Corporation (4883)

カテゴリー

Modalis Therapeutics Corporation(4883)の株価履歴
終値の最高値: $0.21 (2026-08-01)

終値の最安値: $27.70 (2020-08-01)
Modalis Therapeutics Corporation の株価履歴(2020 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 4.62%
2025 -47.79%
2024 -8.66%
2023 -67.25%
2022 -58.62%
2021 -72.31%
2020 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$740.28 6.71%
CH
$1.07K -5.58%
KR